JK184,
315703-52-7,
JK184,
JK 184,
N-(4-ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)thiazol-2-amine,
CHEMBL514622,
Hh Signaling Antagonist VII, JK184,
N-(4-ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-amine,
N-(4-Ethoxyphenyl)-4-(2-methylimidazo-[1,2-a]pyridin-3-yl)thiazol-2-amine,
N-(4-ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-thiazolamine,
SHH Antagonist,
HH SIGNALING ANTAGONIST VII,
AC1LLM6T,
Oprea1_052741,
Oprea1_737598,
MLS006010845,
SCHEMBL1684541,
CTK8B9469,
DTXSID70360042,
HMS3677J10,
ZINC755692,
BCP21568,
EX-A1098,
KS-00001D4N,
ANW-62571,
BDBM50249523,
MFCD01044465,
AKOS016003923,
JK184/ JK-184,
API0014024,
CS-6080,
NCGC00263211-01,
NCGC00263211-05,
AC-27420,
AJ-23857,
AK101893,
HY-13307,
QC-10205,
SMR004701770,
AX8233432,
RT-013247,
703H527,
J-018471,
3-[2-[(4-Ethoxyphenyl)amino]thiazole-4-yl]-2-methylimidazo[1,2-a]pyridine,
2-Thiazolamine, N-(4-ethoxyphenyl)-4-(2-methylimidazo(1,2-a)pyridin-3-yl)-,
C19H18N4OS,
JK-184,
CID1069686,
CID 1069686,
A8652,
A12925,
C525593,